Punicalin

Research use only, not for human use.

Punicalin exerts anti-inflammatory antioxidative and anti-hepatotoxic activities it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner with an IC50 of 0.11 microg/ml (0.14 microM).

Punicalin exerts anti-inflammatory antioxidative and anti-hepatotoxic activities it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner with an IC50 of 0.11 microg/ml (0.14 microM).

Western Blot Analysis Cell Line:J774A Concentration:0, 25, 50, 100 μM Incubation Time:The cells were pretreated with punicalin for one hour, followed by treated with Lipopolysaccharide (HY-D1056) for 5.5 h, ATP for half an hour, respectively.Result:Reduced the increased protein expression of NLRP3, ASC, Caspase-1 and GSDMD-N.Cell Cycle Analysis Cell Line:SH-SY5Y Concentration:10, 20 μM Incubation Time:24-72 h Result:Alleviated the rising of the G0/G1 phase ratio.Ameliorated OGD/R-mediated expression of cyclin B1, CDK1, p21 and phosphorylation of CDK1 at 20 μM.Cell Viability Assay Cell Line:J774A Concentration:0, 25, 50, 100 μM Incubation Time:24 h Result:Promoted cell viability and decreased the release of pro-inflammatory cytokines.

Animal Model:Carrageenan (HY-125474)-induced Edema in rats Dosage:5 mg/kg Administration:s.c.Result:Showed significant anti-inflammatory effect against carrageenan induced paw edema at all time intervals, but decreased the effects.with larger dose.Animal Model:LPS (HY-D1056)-induced acute lung injury mice Dosage:10 mg/kg Administration:i.p.Result:Reduced the mortality and attenuated the severity of lung pathological injury.Ameliorated LPS (HY-D1056)-induced lung edema and vascular leakage.

——

Microbiology/Virology

HIV

HIV-1

——

——

65995-64-4

782.52

C34H22O22

>98% (HPLC)

In Vitro:?H2O : 50 mg/mL (63.90 mM)

OC1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c4oc(=O)c5c(c(O)c(O)c6oc(=O)c3c4c56)-c3c(O)c(O)c(O)cc3C(=O)O[C@H]2[C@H](O)[C@H]1O

——

(-20℃)

With Ice Pack

≥ 2 years